SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-048118
Filing Date
2024-02-27
Accepted
2024-02-27 17:21:34
Documents
5
Effectiveness Date
2024-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 d769709ds8.htm S-8 41712
2 EX-5.1 d769709dex51.htm EX-5.1 7993
3 EX-23.1 d769709dex231.htm EX-23.1 1595
4 EX-FILING FEES d769709dexfilingfees.htm EX-FILING FEES 30598
5 GRAPHIC g769709g0227042705401.jpg GRAPHIC 2510
  Complete submission text file 0001193125-24-048118.txt   86596
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277423 | Film No.: 24688619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)